Utah has signed a new agreement with Legion Health that allows an AI system to renew a limited set of previously prescribed psychiatric medications under the state’s AI Learning Laboratory program.
The agreement was signed in mid-March and posted last week, putting the latest mental health version of the state’s refill experiment at the center of the debate.
The chatbot cannot diagnose, start treatment, change doses, or switch medications. It can only authorize renewals for a defined formulary of non-controlled maintenance psychiatric drugs under a 12-month regulatory mitigation agreement, with mandatory human escalation for out-of-scope or higher-risk cases.
What Utah actually approved
The full Legion agreement says the pilot applies to Utah residents receiving services while physically located in the state and limits the program to renewals of previously prescribed psychiatric medications. The formulary includes antidepressants and related maintenance drugs, including fluoxetine, sertraline, escitalopram, citalopram, paroxetine, venlafaxine XR, desvenlafaxine, duloxetine, bupropion SR and XL, trazodone, mirtazapine, buspirone, and hydroxyzine.
The same agreement excludes controlled substances, benzodiazepines and hypnotics, antipsychotics, lithium, valproate, clozapine, and medications that require new lab work or ECG monitoring for safe renewal.
Utah’s public summary also makes the state’s position explicit: this is regulatory mitigation, not endorsement. The state says it is temporarily removing some enforcement barriers so it can gather real-world evidence before deciding whether permanent legal changes make sense. The agreement also says the mitigation does not waive liability or legal remedies if a patient is harmed.
What makes this pilot different
The agreement requires the AI to escalate any case involving suicidality or self-harm signals, mania or hypomania flags, pregnancy-related status changes, severe adverse effects, worsening symptoms, or identity or prescription mismatches. Patients can request human review at any point, pharmacists can escalate cases, and urgent reviews are supposed to reach a provider queue within 24 business hours.
The pilot is also staged. For the first 250 renewal requests, a Utah-licensed clinician must review the case before anything is sent to the pharmacy, and Legion must reach more than 98% concordance to move forward. The next 1,000 cases receive retrospective review and must clear a 99% concordance threshold before the pilot moves to ongoing sampling and incident-driven audits. Monthly reports must include accepted and denied renewals, concordance rates, complaints, and adverse outcomes.
That still leaves the broader criticism intact. A March JAMA Health Forum analysis of Utah’s earlier Doctronic pilot found that the state had established meaningful guardrails but also highlighted limited pre-deployment evidence, unresolved accountability questions, and the need for independent evaluation and public performance reporting.
Utah’s Legion agreement responds with tighter psychiatric restrictions and a clearer audit structure, but it does not settle the question of whether chatbot-led mental health renewals are simply administratively efficient or clinically safe at scale.
Also read: AI breakthroughs and industry shakeups defining 2026.